BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 14, 2020
View Archived Issues
Amgen studies AMG-256 for advanced solid tumors in phase I trial
Read More
Following neonatal lead enables spinal cord repair in mice
Read More
T-cell 'repliclones' can thwart HIV drugs
Read More
Fat-free mice have bigger bones
Read More
Test tube HIV enables replication insights
Read More
Jiangsu Provincial Center for Disease Control and Prevention patents anti-coronavirus MAbs
Read More
Kinnate Biopharma discovers c-RAF inhibitors
Read More
Topline phase III results show noninferiority of OPC-61815 versus tolvaptan tablets
Read More
Exciting toxicity study implicates TRPM4 in NMDA-mediated cell death
Read More
Interim data from FIDES-02 study of derazantinib in advanced urothelial cancer
Read More
Fujitsu and PeptiDream announce milestone under joint research effort
Read More
Additional interim data presented for WP-1066 in adult glioblastoma
Read More
Direct AMPK activator opposes mitochondrial dysfunction, oxidative stress and inflammation in DPN
Read More
New STING agonists identified at Lupin
Read More
Sumitomo Dainippon Pharma Oncology presents new PKM2 activators
Read More
Shanghai Ringene Biopharma synthesizes new BRD and/or c-Myc inhibitors
Read More
AnaptysBio reports topline data from phase II GALLOP study of imsidolimab in GPP
Read More
First patient dosed in phase I study of NBTXR-3 in pancreatic cancer
Read More
Gossamer Bio presents topline phase II data for GB-001
Read More
Targeting Ire1-alpha may reduce cystic fibrosis airway inflammation
Read More
CARB-X award supports development of Polyphor antibiotic program
Read More
New phase I trial evaluates liposomal hydroxychloroquine TLC-19 for COVID-19
Read More
Derazantinib active in intrahepatic cholangiocarcinoma with FGFR2 mutations/amplifications
Read More
Allob shows 90% fusion rate at 24 months in phase IIa study in lumbar spinal fusion
Read More
FDA grants expanded access to ExoFlo for COVID-19-associated ARDS
Read More